Background The heterogeneity of malaria transmission makes widespread elimination a
difficult goal to achieve. Most of the current vector control measures insufficiently target …

Ivermectin is an endectocide that has been used broadly in single dose community
campaigns for the control of onchocerciasis and lymphatic filariasis for more than 30 years …

Mosquito-borne diseases are an increasing global health challenge, threatening over 40%
of the world's population. Despite major advances in malaria control since 2000, recent …

Background Ivermectin is widely used in mass drug administrations for controlling neglected
parasitic diseases, and can be lethal to malaria vectors that bite treated humans. Therefore …

Efforts at elimination of scourges, such as malaria, are limited by the logistic challenges of
reaching large rural populations and ensuring patient adherence to adequate …

Parasitic diseases still pose a serious threat to human and animal health, particularly for
millions of people and their livelihoods in low-income countries. Therefore, research into the …

In the context of stalling progress against malaria, resistance of mosquitoes to insecticides,
and residual transmission, mass drug administration (MDA) of ivermectin, an endectocide …

Ivermectin is a pivotal drug for the control of onchocerciasis and lymphatic filariasis, which is
increasingly identified as a useful drug for the control of other Neglected Tropical Diseases …

Background Ivermectin (IVM), used alongside mass treatment strategies with an artemisinin
combination therapy, has been suggested as a possible tool for reducing malaria …

Background Mass drug administration (MDA) of ivermectin to humans for control and
elimination of filarial parasites can kill biting malaria vectors and lead to Plasmodium …